Month: December 2022

Wilmington, Delaware–(Newsfile Corp. – December 29, 2022) – Rigrodsky Law, P.A. is investigating Catalyst Biosciences, Inc. (“Catalyst”) (NASDAQ CM: CBIO) regarding possible breaches of fiduciary duties and other violations of law related to Catalyst’s agreement more...

Aileron Therapeutics, Inc. (ALRN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates — one of the most powerful forces impacting stock more...

The biotech sector was in focus with many important pipeline and regulatory updates. Collaboration deals were also in focus. Recap of the Week’s Most Important Stories : Gilead’s HIV Drug Approval : Gilead Sciences, Inc more...

Shares of PDS Biotechnology Corporation PDSB were up 23.8% on Dec 28 after management announced interim data from a phase II study, which evaluated a PDS0101-based triple combination therapy in checkpoint inhibitor (CPI)-naïve and CPI-refractory more...

Shares of Minerva Neurosciences NERV were down 38.9% on Dec 28 after management announced that the FDA’s refuse-to-file letter on the company’s new drug application (“NDA”) filing was still in effect. The NDA filing sought more...

NEW YORK, Dec. 29, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to more...

NEWTON, Mass., Dec. 29, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical more...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Sapiens International Corporation N.V. SPNS : This company that provides software solutions for the insurance and financial services industries has seen more...